Katja Deterding

5.6k total citations
119 papers, 3.3k citations indexed

About

Katja Deterding is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Katja Deterding has authored 119 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Hepatology, 101 papers in Epidemiology and 12 papers in Immunology. Recurrent topics in Katja Deterding's work include Hepatitis C virus research (107 papers), Liver Disease Diagnosis and Treatment (76 papers) and Hepatitis B Virus Studies (70 papers). Katja Deterding is often cited by papers focused on Hepatitis C virus research (107 papers), Liver Disease Diagnosis and Treatment (76 papers) and Hepatitis B Virus Studies (70 papers). Katja Deterding collaborates with scholars based in Germany, United States and France. Katja Deterding's co-authors include Heiner Wedemeyer, Markus Cornberg, Michael P. Manns, Kerstin Port, Jerzy Jaroszewicz, Julia Hengst, Benjamin Maasoumy, C.–Thomas Bock, R. Raupach and Birgit Bremer and has published in prestigious journals such as Nature Communications, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Katja Deterding

112 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Katja Deterding	2.9k	2.9k	372	356	105	119	3.3k
Mary C. Kuhns	2.4k 0.8×	2.6k 0.9×	146 0.4×	377 1.1×	48 0.5×	61	2.8k
Benedetta Massetto	1.9k 0.7×	1.9k 0.6×	174 0.5×	391 1.1×	74 0.7×	44	2.3k
Manfred Wiese	2.0k 0.7×	1.7k 0.6×	396 1.1×	185 0.5×	205 2.0×	48	2.4k
Michèle Martinot‐Peignoux	2.8k 1.0×	2.7k 0.9×	132 0.4×	311 0.9×	337 3.2×	49	3.1k
Robert Perrillo	2.3k 0.8×	2.4k 0.8×	95 0.3×	364 1.0×	49 0.5×	60	2.6k
Harvey J. Alter	1.9k 0.6×	1.7k 0.6×	181 0.5×	329 0.9×	154 1.5×	7	2.4k
Christine J. Weegink	2.2k 0.8×	1.9k 0.7×	108 0.3×	634 1.8×	193 1.8×	53	2.4k
Ming‐Yuh Hsieh	1.9k 0.7×	1.8k 0.6×	92 0.2×	145 0.4×	206 2.0×	72	2.2k
S.V. Feinman	1.9k 0.7×	1.8k 0.6×	108 0.3×	194 0.5×	199 1.9×	36	2.3k
Olle Reichard	1.7k 0.6×	1.5k 0.5×	152 0.4×	211 0.6×	233 2.2×	39	1.9k

Countries citing papers authored by Katja Deterding

Since Specialization

Citations

This map shows the geographic impact of Katja Deterding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Deterding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Deterding more than expected).

Fields of papers citing papers by Katja Deterding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Deterding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Deterding. The network helps show where Katja Deterding may publish in the future.

Co-authorship network of co-authors of Katja Deterding

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Deterding. A scholar is included among the top collaborators of Katja Deterding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Deterding. Katja Deterding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bantel, Heike, Peter Buggisch, Andreas Geier, et al.. (2025). Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel. Liver International. 45(8). e70225–e70225. 3 indexed citations

Sandmann, Lisa, Birgit Bremer, Anke Kraft, et al.. (2025). Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection. Liver International. 45(2). e70003–e70003. 1 indexed citations

Deterding, Katja, Kerstin Port, Lisa Sandmann, et al.. (2025). TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D. Hepatology. 82(6). 1565–1581. 3 indexed citations

Gupta, Manoj Kumar, Birgit Bremer, Katja Deterding, et al.. (2024). Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition. Hepatology. 82(3). 739–754. 1 indexed citations

Jachs, Mathias, Lisa Sandmann, Lukas Hartl, et al.. (2024). Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. Zeitschrift für Gastroenterologie. 62(1). e24–e24. 4 indexed citations

Siederdissen, Christoph Höner zu, Birgit Bremer, Katja Deterding, et al.. (2024). Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients. Journal of Viral Hepatitis. 32(4). e14026–e14026.

Reiberger, Thomas, Sabela Lens, Giuseppe Cabibbo, et al.. (2024). EASL position paper on clinical follow-up after HCV cure. Journal of Hepatology. 81(2). 326–344. 25 indexed citations

Jachs, Mathias, Lisa Sandmann, Lukas Hartl, et al.. (2024). Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. Journal of Hepatology. 81(2). 248–257. 7 indexed citations

Bremer, Birgit, Carola Mix, Tammo Lambert Tergast, et al.. (2024). Limited stability of Hepatitis B virus RNA in plasma and serum. Scientific Reports. 14(1). 27128–27128.

10.

Wagner, L. S., H. Schneider, Andreas Tiede, et al.. (2023). Die Anlage eines transjugulären intrahepatischen portosystemischen Shunts bei Patient:innen mit dekompensierter Leberzirrhose ist mit einer signifikanten Verbesserung der Lebensqualität assoziiert. Zeitschrift für Gastroenterologie. 61(8). e479–e480. 1 indexed citations

11.

Deterding, Katja, Cheng‐Jian Xu, Kerstin Port, et al.. (2023). Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA. Journal of Viral Hepatitis. 30(7). 597–606. 11 indexed citations

12.

Deterding, Katja, Birgit Bremer, Kerstin Port, et al.. (2023). Kinetics and predictive value of HBcrAg, HBV RNA and anti‐HBc during bulevirtide treatment of chronic HDV‐infected patients. Journal of Viral Hepatitis. 30(4). 283–286. 6 indexed citations

13.

Anastasiou, Olympia E., et al.. (2021). Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients. Medicine. 100(28). e26571–e26571. 10 indexed citations

14.

Du, Yanqin, Benedikt Strunz, Katja Deterding, et al.. (2021). Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment. European Journal of Immunology. 52(3). 472–483. 10 indexed citations

15.

Strunz, Benedikt, Julia Hengst, Katja Deterding, et al.. (2018). Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity. Nature Communications. 9(1). 2275–2275. 64 indexed citations

16.

Deterding, Katja, Dina Attia, Kristina I. Ringe, et al.. (2018). Long‐term changes in liver elasticity in hepatitis C virus‐infected patients with sustained virologic response after treatment with direct‐acting antivirals. United European Gastroenterology Journal. 6(8). 1188–1198. 27 indexed citations

17.

Deterding, Katja, Christoph Höner zu Siederdissen, Kerstin Port, et al.. (2015). Improvement of liver function parameters in advanced HCV ‐associated liver cirrhosis by IFN ‐free antiviral therapies. Alimentary Pharmacology & Therapeutics. 42(7). 889–901. 87 indexed citations

18.

Wiegand, Steffen B., Jerzy Jaroszewicz, Andrej Potthoff, et al.. (2015). Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients. Clinical Microbiology and Infection. 21(7). 710.e1–710.e9. 40 indexed citations

19.

Maasoumy, Benjamin, Steffen B. Wiegand, Jerzy Jaroszewicz, et al.. (2015). Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. Clinical Microbiology and Infection. 21(6). 606.e1–606.e10. 111 indexed citations

20.

Mederacke, Ingmar, Sandra Ciesek, R. Raupach, et al.. (2009). 333 KINETICS OF HCV CORE ANTIGEN DURING ANTIVIRAL TREATMENT OF ACUTE AND CHRONIC HEPATITIS C AS DETERMINED BY A NOVEL CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY. Journal of Hepatology. 50. S129–S129. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact